Portfolio - Asabys Partners

Portfolio

October 29, 2024

INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology

READ THIS NEWS IN SPANISH VC funding led by imec.xpand, with significant participation from the…

Mark

Portfolio

September 26, 2024

Asabys Announces the Closing of €180M Oversubscribed Sabadell Asabys II Fund

READ THIS NEWS IN SPANISH New fund is investing across the board in life sciences…

Mark

Portfolio

October 22, 2024

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study

Serial entrepreneur and medical device industry executive adds key experience to board of directors Gradient…

Mark

Portfolio

June 26, 2024

Augustine Therapeutics Raises Eur 17 Million In A Series A First Closing To Advance Lead Candidate Into Clinical Development In Neurological Diseases

READ THIS NEWS IN SPANISH Proceeds will advance lead candidate AGT100216, a peripherally restricted and…

Mark

Portfolio

March 12, 2024

Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions

READ THIS NEWS IN SPANISH Acquisition adds four digital treatment programs targeting significant populations to…

Mark

Portfolio

March 11, 2024

Gradient Denervation Technologies Enrolls First Patient in Early Feasibility Study of Pulmonary Artery Denervation System

FDA-Approved US study intended to evaluate pulmonary artery denervation in heart failure patients with WHO…

Mark

Portfolio

January 10, 2024

XRHealth Secures $6 Million in Funding Led By Asabys Partners and Welcomes NOVA Prime as a New Investor

Funding will Support Development of AI Clinician, Using Spatial Computing XRHealth, the leading healthcare platform in Spatial…

Mark

Portfolio

November 30, 2023

ALLOX, a new Centre for Genomic Regulation spin-off, is launched with the support of Asabys

READ THIS NEWS IN SPANISH ALLOX is a spin-off from the Centre for Genomic Regulation…

Mark

Portfolio

October 17, 2023

SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease

READ THIS NEWS IN SPANISH SpliceBio is eligible to receive upfront, opt-in and milestone payments…

Mark

Portfolio

October 11, 2023

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

READ THIS NEWS IN SPANISH Round led by Fidelity Management & Research Company with participation…

Mark

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others